Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
Alvise SernicolaAnna ColpoAnca Irina LeahuMauro AlaibacPublished in: Medicina (Kaunas, Lithuania) (2022)
In the field of advanced melanoma, there is an urgent need to investigate novel approaches targeting specific components of the cancer-immunity cycle beyond immune checkpoint inhibitors. The authors reviewed the basic understanding of the role of neutrophils in cancer biology, and the latest clinical evidence supporting the correlation between cancer-associated neutrophils and the prognosis and response to the immunotherapy of advanced melanoma. Finally, they propose that granulocyte and monocyte apheresis, an emerging non-pharmacological treatment in current dermatology, could become an investigative treatment targeting melanoma-associated neutrophils which could be potentially used in combination with the usual immune checkpoint inhibitors.